Using multivariate logistic regression analysis, the final model consisted of four significant parameters, namely diagnosis (HCC versus ICC), pre-treatment CP classification (CP-A versus CP-B or C), HBV/HCV infection status (positive versus negative) and MLD. This evidence concerns the gene CPA1 and intrahepatic cholangiocarcinoma.